Recruitment of immune cells across atrial endocardium in human atrial fibrillation.

BACKGROUND Although clinical studies have suggested a link between inflammation markers and atrial fibrillation (AF), it is still unclear whether local immunologic responses actually exist in human atria during AF. METHODS AND RESULTS To address this point, human left appendages were obtained from 16 patients who underwent cardiac surgery (5 with sinus rhythm (SR) and 11 with AF) and subjected to immunohistochemical analysis. In all the AF specimens, adhesion and migration of CD45-reactive cells were consistently observed predominantly in the atrial endo- and subendomyocardium and more prominently than in SR. Most of them were immunologically active CD68-positive macrophages, whereas CD3-positive T cells infiltrated to a lesser extent. Scavenger-receptor A staining revealed maturation of macrophages not in the endocardium but in the midmyocardium, a gradient from endo- to midmyocardium. In the endocardium, along with adhesion molecules (intracellular adhesion molecule-1 and vascular cell adhesion molecule-1), a chemotactic protein-1, which facilitates the recruitment, was more abundantly expressed in AF than in SR. Cytokines including transforming growth factor-beta and interleukin-6 were frequently expressed by these macrophages. CONCLUSIONS These observations collectively imply active adhesion and recruitment of macrophages across the endocardium in human fibrillating atria, thereby supporting the concept of local immunologic inflammatory responses around the atrial endocardium of AF.

[1]  M. Hirai,et al.  Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[2]  G. Ávila,et al.  Role of TGF-β on cardiac structural and electrical remodeling , 2008, Vascular health and risk management.

[3]  T. Uejima,et al.  Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[4]  A. Goette,et al.  Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression , 2008, Circulation.

[5]  N. Lakkis,et al.  Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. , 2007, Journal of the American College of Cardiology.

[6]  D. Kass,et al.  Hemodynamic Modulation of Endocardial Thromboresistance , 2006, Circulation.

[7]  D. Katritsis Is atrial fibrillation an inflammatory disorder? , 2006, European heart journal.

[8]  J. Svendsen,et al.  Inflammation in the genesis and perpetuation of atrial fibrillation. , 2005, European heart journal.

[9]  J. Langberg,et al.  Atrial Fibrillation Increases Production of Superoxide by the Left Atrium and Left Atrial Appendage: Role of the NADPH and Xanthine Oxidases , 2005, Circulation.

[10]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[11]  Å. Sjöholm,et al.  Endothelial inflammation in insulin resistance , 2005, The Lancet.

[12]  G. Lip,et al.  Endothelial dysfunction: methods of assessment and application to hypertension. , 2004, Current pharmaceutical design.

[13]  J. Dernellis,et al.  Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. , 2004, European heart journal.

[14]  G Hindricks,et al.  Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease , 2004, Heart.

[15]  Bruce M Psaty,et al.  Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.

[16]  R. Goldberg,et al.  Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. , 2003, The American journal of cardiology.

[17]  C. Lau,et al.  Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. , 2003, The American journal of cardiology.

[18]  TakeshiYamashita,et al.  Thrombomodulin and Tissue Factor Pathway Inhibitor in Endocardium of Rapidly Paced Rat Atria , 2003 .

[19]  I. Gelder,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2003 .

[20]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[21]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.

[22]  A. Goette,et al.  Downregulation of Endocardial Nitric Oxide Synthase Expression and Nitric Oxide Production in Atrial Fibrillation: Potential Mechanisms for Atrial Thrombosis and Stroke , 2002, Circulation.

[23]  Peter Libby,et al.  Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.

[24]  Zoltan Szalay,et al.  Structural correlate of atrial fibrillation in human patients. , 2002, Cardiovascular research.

[25]  I. V. Van Gelder,et al.  Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. , 2002, Cardiovascular research.

[26]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[27]  I. V. Van Gelder,et al.  Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design. , 2002, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[28]  Cynthia A. Carnes,et al.  C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.

[29]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[30]  K. V. van Dijk,et al.  Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[31]  R. Terkeltaub,et al.  Chemokines and atherosclerosis. , 1998, Current opinion in lipidology.

[32]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[33]  R. Ross,et al.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[34]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[35]  D. Steinberg,et al.  Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Wolf,et al.  Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. , 1985, JAMA.

[37]  A. Waldo Increased Inflammatory Cell Infiltration in the Atrial Myocardium of Patients With Atrial Fibrillation , 2009 .

[38]  A. Waldo Angiotensin II Receptor Blockade Reduces New-Onset Atrial Fibrillation and Subsequent Stroke Compared to Atenolol: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) Study , 2006 .

[39]  R. Kronmal,et al.  Relation of Elevated C-Reactive Protein and Interleukin-6 Levels to Left Atrial Size and Duration of Episodes in Patients With Atrial Fibrillation , 2005 .

[40]  T. Ohe,et al.  Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. , 2003, Thrombosis research.

[41]  B L Langille,et al.  Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. , 1995, Arteriosclerosis, thrombosis, and vascular biology.